Lung Cancer Screening Protocol
- Conditions
- Lung Cancer Screening
- Registration Number
- NCT03958253
- Lead Sponsor
- Washington University School of Medicine
- Brief Summary
The successful implementation of lung cancer screening across diverse setting requires working with the community and primary care practices. Collaborating across diverse community-based sites will employ local knowledge and culture in the understanding of the health problem and identifying and implementing solutions that are appropriate for all partners (patients, primary care, referral centers). Enhanced, culturally-competent communication with patients at high risk for lung cancer can narrow inequities in screening awareness, referral, and utilization, as well as improve lung cancer outcomes across diverse patients and communities. Promoting partnerships among physicians, staff, and patients; creating routines; and tailoring materials to each clinician's situation have been show to increase the proportion of patients receiving screening.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 193
- To be eligible to participate in the trial, screening centers have to be existing members of the BJC Collaborative.
- Primary Care Providers have to have a referral relationship with the screening center; serve adult patients who may be screening-eligible, and are willing to interact with the referral site to implement referral for LDCT.
There are not any exclusion criteria for the study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SEQUENTIAL
- Primary Outcome Measures
Name Time Method Number of initial low-dose CT (LDCT) scan screenings per month per screening center Completion of study (estimated to be 21 months) -Screening will be defined as completed initial screen for lung cancer
- Secondary Outcome Measures
Name Time Method Number of primary care providers who refer at least two patients per month for LDCT Completion of study (estimated to be 21 months) Percent of patients referred who are screen-eligible Completion of study (estimated to be 21 months) Defined as the number of screen-eligible patients divided by the total of screening procedures performed
Percent of patients referred who complete screening Completion of study (estimated to be 21 months) Defined as the number of patients referred for screening divided by the total number of screening procedures performed.
Trial Locations
- Locations (7)
Southern Illinois Healthcare
🇺🇸Carbondale, Illinois, United States
Decatur Memorial Hospital
🇺🇸Decatur, Illinois, United States
Sarah Bush Lincoln Health System
🇺🇸Mattoon, Illinois, United States
Memorial Health System
🇺🇸Springfield, Illinois, United States
Washington University School of Medicine
🇺🇸Saint Louis, Missouri, United States
BJC HealthCare, Barnes-Jewish St. Peters Hospital
🇺🇸Saint Peters, Missouri, United States
CoxHealth
🇺🇸Springfield, Missouri, United States
Southern Illinois Healthcare🇺🇸Carbondale, Illinois, United States